Adjuvant rituximab therapy of pemphigus: a single center experience with 31 patients

BACKGROUND: We conducted a retrospective study of pemphigus vulgaris (n=24) and foliaceus (n=7) patients treated with adjuvant rituximab to determine efficacy and adverse events. The endpoint for efficacy was complete remission of disease on no or minimal therapy. OBSERVATIONS: 18 patients (58%) ach...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lunardon, Luisa, Tsai, Kathleen J., Propert, Kathleen J., Fett, Nicole, Stanley, John R., Werth, Victoria P., Tsai, Donald E., Payne, Aimee S.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3658473/
https://ncbi.nlm.nih.gov/pubmed/22710375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archdermatol.2012.1522
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars